Faraday Pharmaceuticals Inc.
- Address
- 1616 Eastlake Avenue East Suite 560
Sponsor Overview
Specializations
Cardiovascular Medicine
Clinical research is centered on anterior ST-elevation myocardial infarction, with attention to acute myocardial infarction care and outcomes following percutaneous coronary intervention.
- Acute coronary syndromes
- STEMI management
- Reperfusion therapy
The therapeutic focus includes reducing cardiovascular mortality and limiting the development of heart failure after a major ischemic cardiac event.
Heart Failure Prevention
Research activity also extends to post-infarction complications, particularly the prevention of heart failure events in patients recovering from a large anterior myocardial infarction.
- Post-infarction remodeling
- Left ventricular dysfunction
- Cardiac event reduction
The clinical emphasis is on preserving cardiac function after ischemic injury and addressing early complications linked to poor long-term prognosis.
Acute Hospital Cardiology
The sponsor’s trial portfolio involves inpatient treatment settings for patients with acute myocardial infarction, reflecting interest in urgent cardiovascular care pathways and immediate post-event management.
- Emergency cardiac care
- Coronary revascularization
- In-hospital outcomes
This area of research aligns with strategies that address the most critical period following coronary artery occlusion.
Multicenter Cardiovascular Trials
Clinical development is carried out across a broad network of collaborating sites in multiple countries, supporting research in cardiovascular therapeutics for patients with ST-elevation myocardial infarction.
- International site collaboration
- Cardiac clinical research networks
- Global enrollment in cardiology
The sponsor’s active interest is concentrated on advancing treatment options for severe ischemic heart disease in diverse clinical settings.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 3 Randomized Double-Blind Placebo-Controlled Study of Intravenous Sodium Iodide (FDY-5301) in Anterior ST-Elevation Myocardial Infarction Patients |  Czechia Germany Hungary Italy Poland Portugal Slovakia Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 81 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
81 centres- Address
- Ul. Aleje Raclawickie 23, 20-049 Lublin
- Address
- Ul. Rudolfa Weigla 5, 53-114 Wroclaw
- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- Via Ferdinando Magellano 1, 10128 Turin
- Address
- Via Ferdinando Palasciano Snc, 81100 Caserta
- Address
- Viale Antonio Gramsci 14, 43126 Parma
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Faraday Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.